NAVB logo

NAVB Accounts Payable

Annual Accounts Payable

$2.12 M
+$701.20 K+49.34%

December 31, 2022


Summary


Performance

NAVB Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNAVBbalance sheetmetrics:

Quarterly Accounts Payable

$2.07 M
+$62.80 K+3.13%

September 30, 2023


Summary


Performance

NAVB Quarterly Accounts Payable Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherNAVBbalance sheetmetrics:

Accounts Payable Formula

Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers

NAVB Accounts Payable Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year+49.3%+3.1%
3 y3 years+90.9%+3.1%
5 y5 years+148.3%+3.1%

NAVB Accounts Payable Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-yearat high+49.3%-34.7%+45.7%
5 y5-yearat high+90.9%-34.7%+91.7%
alltimeall time-58.9%+967.1%-59.9%+1123.0%

Navidea Biopharmaceuticals Accounts Payable History

DateAnnualQuarterly
Sep 2023
-
$2.07 M(+3.1%)
Jun 2023
-
$2.01 M(-36.7%)
Mar 2023
-
$3.17 M(+49.4%)
Dec 2022
$2.12 M(+49.3%)
$2.12 M(+22.1%)
Sep 2022
-
$1.74 M(-28.4%)
Jun 2022
-
$2.43 M(+55.1%)
Mar 2022
-
$1.56 M(+10.1%)
Dec 2021
$1.42 M(+22.3%)
$1.42 M(+17.8%)
Sep 2021
-
$1.21 M(+11.7%)
Jun 2021
-
$1.08 M(-12.5%)
Mar 2021
-
$1.23 M(+6.2%)
Dec 2020
$1.16 M(+4.5%)
$1.16 M(+4.1%)
Sep 2020
-
$1.12 M(-3.9%)
Jun 2020
-
$1.16 M(-20.2%)
Mar 2020
-
$1.45 M(+30.8%)
Dec 2019
$1.11 M(+161.9%)
$1.11 M(+32.6%)
Sep 2019
-
$839.00 K(+24.7%)
Jun 2019
-
$673.00 K(-21.1%)
Mar 2019
-
$852.60 K(+100.8%)
Dec 2018
$424.70 K(-50.3%)
$424.70 K(-31.0%)
Sep 2018
-
$615.50 K(+35.7%)
Jun 2018
-
$453.70 K(-35.2%)
Mar 2018
-
$700.20 K(-18.1%)
Dec 2017
$855.00 K(-83.4%)
$855.00 K(-30.5%)
Sep 2017
-
$1.23 M(-23.3%)
Jun 2017
-
$1.60 M(-48.8%)
Mar 2017
-
$3.13 M(-39.3%)
Dec 2016
$5.17 M(+192.2%)
$5.17 M(+5.5%)
Sep 2016
-
$4.89 M(-4.7%)
Jun 2016
-
$5.13 M(+77.0%)
Mar 2016
-
$2.90 M(+64.2%)
Dec 2015
$1.77 M(+19.6%)
$1.77 M(+36.1%)
Sep 2015
-
$1.30 M(-4.3%)
Jun 2015
-
$1.36 M(-28.8%)
Mar 2015
-
$1.91 M(+29.0%)
Dec 2014
$1.48 M(-39.0%)
$1.48 M(-37.8%)
Sep 2014
-
$2.38 M(+42.0%)
Jun 2014
-
$1.67 M(-31.0%)
Mar 2014
-
$2.43 M(+0.2%)
Dec 2013
$2.42 M(+70.9%)
$2.42 M(+42.1%)
Sep 2013
-
$1.70 M(-41.0%)
Jun 2013
-
$2.89 M(+54.8%)
Mar 2013
-
$1.87 M(+31.6%)
Dec 2012
$1.42 M(+107.9%)
$1.42 M(-28.1%)
Sep 2012
-
$1.97 M(+101.2%)
Jun 2012
-
$979.50 K(+23.7%)
Mar 2012
-
$792.00 K(+16.2%)
Dec 2011
$681.80 K(-55.2%)
$681.80 K(-34.4%)
Sep 2011
-
$1.04 M(-34.1%)
Jun 2011
-
$1.58 M(+83.7%)
Mar 2011
-
$859.10 K(-43.6%)
Dec 2010
$1.52 M(+99.4%)
$1.52 M(-22.4%)
Sep 2010
-
$1.96 M(+43.0%)
Jun 2010
-
$1.37 M(+25.7%)
Mar 2010
-
$1.09 M(+42.9%)
Dec 2009
$764.00 K(+5.3%)
$764.00 K(-1.1%)
Sep 2009
-
$772.50 K(+44.2%)
Jun 2009
-
$535.80 K(-22.6%)
Mar 2009
-
$692.30 K(-4.6%)
Dec 2008
$725.80 K
$725.80 K(+3.9%)
Sep 2008
-
$698.60 K(-5.1%)
Jun 2008
-
$736.40 K(-9.7%)
DateAnnualQuarterly
Mar 2008
-
$815.10 K(+4.8%)
Dec 2007
$778.10 K(+16.4%)
$778.10 K(-0.4%)
Sep 2007
-
$781.00 K(-4.8%)
Jun 2007
-
$820.80 K(-11.1%)
Mar 2007
-
$922.90 K(+38.1%)
Dec 2006
$668.30 K(+221.6%)
$668.30 K(+50.7%)
Sep 2006
-
$443.60 K(+57.4%)
Jun 2006
-
$281.90 K(-33.4%)
Mar 2006
-
$423.00 K(+103.6%)
Dec 2005
$207.80 K(+4.5%)
$207.80 K(-32.4%)
Sep 2005
-
$307.20 K(-26.6%)
Jun 2005
-
$418.40 K(+100.8%)
Mar 2005
-
$208.40 K(+4.8%)
Dec 2004
$198.90 K(-11.6%)
$198.90 K(-13.8%)
Sep 2004
-
$230.70 K(-31.4%)
Jun 2004
-
$336.30 K(+1.9%)
Mar 2004
-
$329.90 K(+46.6%)
Dec 2003
$225.00 K(-47.9%)
$225.00 K(-59.2%)
Sep 2003
-
$551.80 K(-0.5%)
Jun 2003
-
$554.30 K(+25.7%)
Mar 2003
-
$441.00 K(+2.1%)
Dec 2002
$432.10 K(-11.8%)
$432.10 K(+155.2%)
Sep 2002
-
$169.30 K(-48.4%)
Jun 2002
-
$328.10 K(+14.6%)
Mar 2002
-
$286.20 K(-41.6%)
Dec 2001
$489.70 K(-33.1%)
$489.70 K(-8.4%)
Sep 2001
-
$534.50 K(-13.2%)
Jun 2001
-
$615.70 K(+75.9%)
Mar 2001
-
$350.00 K(-52.2%)
Dec 2000
$732.00 K(-3.7%)
$732.00 K(+127.0%)
Sep 2000
-
$322.40 K(-68.1%)
Jun 2000
-
$1.01 M(+124.1%)
Mar 2000
-
$451.30 K(-79.5%)
Dec 1999
$760.00 K(-73.4%)
-
Jun 1999
-
$2.20 M(+10.0%)
Mar 1999
-
$2.00 M(-30.0%)
Dec 1998
$2.86 M(-25.7%)
$2.86 M(+119.8%)
Sep 1998
-
$1.30 M(-31.6%)
Jun 1998
-
$1.90 M(-38.7%)
Mar 1998
-
$3.10 M(-19.4%)
Dec 1997
$3.85 M(+60.3%)
$3.85 M(+92.4%)
Sep 1997
-
$2.00 M(+5.3%)
Jun 1997
-
$1.90 M(+72.7%)
Mar 1997
-
$1.10 M(-54.2%)
Dec 1996
$2.40 M(-4.0%)
$2.40 M(+26.3%)
Sep 1996
-
$1.90 M(+46.2%)
Jun 1996
-
$1.30 M(+8.3%)
Mar 1996
-
$1.20 M(-52.0%)
Dec 1995
$2.50 M(+56.3%)
$2.50 M(+177.8%)
Sep 1995
-
$900.00 K(-10.0%)
Jun 1995
-
$1.00 M(-23.1%)
Mar 1995
-
$1.30 M(-18.8%)
Dec 1994
$1.60 M(+23.1%)
$1.60 M(+14.3%)
Sep 1994
-
$1.40 M(+75.0%)
Jun 1994
-
$800.00 K(-46.7%)
Mar 1994
-
$1.50 M(+15.4%)
Dec 1993
$1.30 M(+160.0%)
$1.30 M(0.0%)
Sep 1993
-
$1.30 M(+160.0%)
Jun 1993
-
$500.00 K(0.0%)
Mar 1993
-
$500.00 K(0.0%)
Dec 1992
$500.00 K
$500.00 K(+66.7%)
Sep 1992
-
$300.00 K

FAQ

  • What is Navidea Biopharmaceuticals annual accounts payable?
  • What is the all time high annual accounts payable for Navidea Biopharmaceuticals?
  • What is Navidea Biopharmaceuticals annual accounts payable year-on-year change?
  • What is Navidea Biopharmaceuticals quarterly accounts payable?
  • What is the all time high quarterly accounts payable for Navidea Biopharmaceuticals?
  • What is Navidea Biopharmaceuticals quarterly accounts payable year-on-year change?

What is Navidea Biopharmaceuticals annual accounts payable?

The current annual accounts payable of NAVB is $2.12 M

What is the all time high annual accounts payable for Navidea Biopharmaceuticals?

Navidea Biopharmaceuticals all-time high annual accounts payable is $5.17 M

What is Navidea Biopharmaceuticals annual accounts payable year-on-year change?

Over the past year, NAVB annual accounts payable has changed by +$701.20 K (+49.34%)

What is Navidea Biopharmaceuticals quarterly accounts payable?

The current quarterly accounts payable of NAVB is $2.07 M

What is the all time high quarterly accounts payable for Navidea Biopharmaceuticals?

Navidea Biopharmaceuticals all-time high quarterly accounts payable is $5.17 M

What is Navidea Biopharmaceuticals quarterly accounts payable year-on-year change?

Over the past year, NAVB quarterly accounts payable has changed by +$62.80 K (+3.13%)